Cure Alzheimer's Fund

Why

5.3 million Americans have Alzheimer's disease

How

We are the only group with a clear plan to CURE this disease

Blog

Groundbreaking Study: Alzheimer’s-associated gene may be part of innate immune system

From Cure Alzheimer's Fund President & CEO, Tim Armour: Exciting news! Breakthrough research conducted by our very own Dr. Rudy Tanzi and his team at Massachusetts General Hospital has led to an important advancement in the understanding of the protein associated with Alzheimer’s disease. Accor... (Read more)
Following the A-beta Trail

Most researchers agree that the amyloid beta peptide, A-beta, is a key player in Alzheimer’s disease pathology. Exactly how it is involved is still unclear; but attention is now shifting from A-beta as the main component of the tell-tale amyloid plaques to the basic component in A-beta “oligomer... (Read more)

Who We Remember

Aaron Alexander Welton, Jr.
Lola Kromka
Annie Pearl Richardson
Muriel Rush Visconti
Jesus Perez
Richard Studley
Agnes Quinton
Anne Laporta
Clarence L. Palmer, Jr.
Goldie Thurmond
Walter Swenton
Reese Shefflett
Mary Helen Moore
Richard Studley
Edith Vicksman
Edna Frances
Maria Dyson
Esther N. Paff
Barbara Delcollo
Joe Mertens

See all gifts in honor and in memory of loved ones

Running 4 Answers

Join us on April 10th for the inaugural "Running 4 Answers" 4-mile race through scenic Roseland and Essex Fells, NJ! All proceeds will benefit Cure Alzheimer's Fund! Visit www.running4answers.org for more information!

Memories Are Everything

Coming Soon!
Alan Arnette is headed back to the mountains, this time planning to climb the highest peak on each continent while raising awareness and funds for Alzheimer’s research. Click here to learn more about Alan’s Memories are Everything trip to Everest.

Join

Phone: 781-237-3800
Email:info@curealzfund.org

Cure Alzheimer's Fund meets all 20 BBB Charity Standards

Community

News

Dr. Rudy Tanzi's Breakthrough Research Featured in New York Times

Breakthrough research conducted by our very own Dr. Rudy Tanzi and his team at Massachusetts General Hospital has led to an important advancement in the understanding of the protein associated with Alzheimer’s disease. The prevailing theory has been that this protein -- A-beta -- has no function ... (Read more)
Research Consortium member Sam Gandy comments on use of imaging technology to test drug effectiveness.

Testing the amyloid hypothesis of Alzheimer’s disease in vivo By Sam Gandy In this issue of The Lancet Neurology, Rinne and colleagues1 report something of a breakthrough by demonstrating the feasibility of eventually testing the so-called amyloid hypothesis of sporadic Alzheimer’s disease in v... (Read more)
Cure Alzheimer's Fund's Rudy Tanzi Comments on Two New Research Findings

Cure Alzheimer's Fund's Dr. Rudy Tanzi was quoted in the Boston Globe in response to two new studies, one ruling out a drug called tarenflurbil and another showing an association between an appetite-controlling hormone and a lower risk of developing Alzheimer's. Click here to read the article

Cure Alzheimer's Fund: Targeting Breakthrough Research

Why